• BD to Invest in Pre-Fillable Syringe Manufacturing Capacity americanpharmaceuticalreview
    December 21, 2020
    BD announced plans to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing ...
PharmaSources Customer Service